Grandix Speciality Formulations Private Limited
About Grandix Speciality Formulations Private Limited
Data last updated:
Grandix Speciality Formulations Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 18 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U21004TN2017PTC120053. Its GSTIN is 33AAHCG1170D1DE (Tamil Nadu). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.5 Lakh. It is led by directors Thangavelu Subramanian and Latha Subramanian.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No. 5 1st Cross Street Kalaimagal Nagar Ekkatuthangal, Chennai, Tamil Nadu, India – 600032.
As per the financials filed for FY 2020, the company reported a revenue of ₹5.5 Lakh, a decline of 94% compared to the previous year. For the same year it recorded a net loss of ₹39.87 Lakh and EBITDA of -₹39.05 Lakh.
The company has about 13 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Grandix Speciality Formulations has one previous CIN (Corporate Identification Number): U51909TN2017PTC120053. The current CIN is U21004TN2017PTC120053, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21004TN2017PTC120053 | Current |
| U51909TN2017PTC120053 | Previous |
Contact details
Grandix Speciality Formulations Private Limited's registered office is in Chennai, Tamil Nadu.
- Registered AddressNo. 5 1st Cross Street Kalaimagal Nagar Ekkatuthangal, Chennai, Tamil Nadu, India – 600032
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Grandix Speciality Formulations Private Limited
FY 2024 filings availableGrandix Speciality Formulations Private Limited reported revenue of ₹5.5 Lakh (down 94% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 94% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹5.5 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹39.05 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹39.87 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Grandix Speciality Formulations Private Limited, buy the company report.
Board of directors of Grandix Speciality Formulations Private Limited
Grandix Speciality Formulations has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Thangavelu Subramanian | Director | 26 Feb 2018 | 8 Years 8 Months | Current |
| Latha Subramanian | Director | 26 Jun 2019 | 7 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Grandix Speciality Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Grandix Speciality Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Grandix Speciality Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCG1170D1DE | Tamil Nadu | Active | 10 Jul 2018 |
To see the full GST registrations and return filing status of Grandix Speciality Formulations Private Limited, buy the company report.
Recent activity
Grandix Speciality Formulations Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Latha Subramanian ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
Grandix Speciality Formulations is an active private limited company based in Chennai, Tamil Nadu, India. The company works in specialty, within the trading industry. It was incorporated on 18 December 2017 (9+ years old) and is registered under CIN U21004TN2017PTC120053.
Grandix Speciality Formulations has 2 current directors:
- Thangavelu Subramanian - Director
- Latha Subramanian - Director
The latest financial statements of Grandix Speciality Formulations on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Grandix Speciality Formulations is 33AAHCG1170D1DE, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Grandix Speciality Formulations is U21004TN2017PTC120053. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Grandix Speciality Formulations was incorporated on 18 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chennai.
Latha Subramanian ceased to be Additional Director on 30 Sep 2019. Latha Subramanian was appointed as Director on 26 Jun 2019. Karnnanidhi Venneela Ramanar ceased to be Director on 09 May 2018. Grandix Speciality Formulations has 4 board changes on record in total.
The registered office of Grandix Speciality Formulations is at No. 5 1st Cross Street Kalaimagal Nagar Ekkatuthangal, Chennai, Tamil Nadu, India – 600032.
Grandix Speciality Formulations operates in the trading industry, in the specialty segment.
The compliance status of Grandix Speciality Formulations is compliant as of 01 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
